Stay updated on Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.

Latest updates to the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedRecord history shows a new Revision: v3.4.3 and removal of Revision: v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded revision v3.4.2 to the record history and removed the older v3.4.1 funding/operating-status notices.SummaryDifference0.9%

- Check41 days agoChange DetectedAdded a site-wide funding notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.9%

- Check48 days agoChange DetectedUI/branding updates including a 'Show glossary' label and color-coded change highlights, plus revision notes. No substantive changes to study data; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check62 days agoChange DetectedThe page history shows the addition of revision v3.3.4 and removal of v3.3.3, which are minor metadata updates to the record and do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedThe Record History shows a new Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.